Published in AIDS Weekly, May 29th, 2000
Their research explains why people who take HIV protease inhibitors are prone to develop diabetes. It suggests that doctors might need to alter the way they test HIV infected patients for diabetes. And it suggests a way to develop new AIDS drugs without the diabetes risk.
"We hope these findings will help improve AIDS therapy while preventing what can be serious complications from a very effective HIV treatment," says Mike M. Mueckler, PhD, the lead scientist for the research that will be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.